BioCorRx Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q2 2011 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: BioCorRx Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q2 2011 to Q2 2025.
BioCorRx Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending June 30, 2025 was $51.2K.

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$51.2K	+$51.2K		Jun 30, 2025	10-Q	2025-08-14
Q1 2025	$112K	+$112K		Mar 31, 2025	10-Q	2025-05-15
Q4 2024	$0	-$740	-100%	Dec 31, 2024	10-Q	2025-08-14
Q3 2024	$0	-$12.2K	-100%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$0			Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$0			Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$740	-$34.6K	-97.9%	Dec 31, 2023	10-K	2025-03-31
Q3 2023	$12.2K			Sep 30, 2023	10-Q	2023-11-14
Q4 2022	$35.4K			Dec 31, 2022	10-K	2024-04-01
Q4 2012	-$926K	-$397K	-75.1%	Dec 31, 2012	10-K	2013-04-15
Q3 2012	-$406K	+$123K	+23.2%	Sep 30, 2012	10-Q	2012-11-19
Q2 2012	-$407K	-$53.4K	-15.1%	Jun 30, 2012	10-Q/A	2012-09-24
Q4 2011	-$529K			Dec 31, 2011	10-K	2013-04-15
Q3 2011	-$529K			Sep 30, 2011	10-Q	2012-11-19
Q2 2011	-$353K			Jun 30, 2011	10-Q/A	2012-09-24

Showing 1 to 15 of 15 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.